4 stories mentioning KRX:000100Updated just now
Every FINWIRES story that references KRX:000100, newest first.
Yuhan (KRX:000100) secured a 78.6 billion won supply contract for active pharmaceutical ingredient (API) from an unnamed global pharmaceutical company, according to a Tuesday filing with the Korea Exchange.The South Korean pharmaceutical company said that the contract runs between Sept. 15, 2026, and July 31, 2028, and represents 3.6% of its 2025 sales.
Yuhan (KRX:000100) won a supply contract for active pharmaceutical ingredient (API) from a global pharmaceutical company, the South Korean pharmaceutical and chemical company said in a Tuesday filing with the Korea Exchange.The supply contract, valued at 131.07 billion won, represents 6% of Yuhan's latest annual sales. The supply contract is valid until May 31, 2028.Shares of Yuhan fell over 1% at market close.
Yuhan (KRX:000100) said a worker died after falling during overhaul work at the Ansan plant of its unit, Yuhan Chemical, on Aug. 24, according to a Tuesday Exchange filing.However, no other injuries were reported. Police and the Ministry of Employment and Labor conducted an on-site inspection, while Yuhan Chemical plans to establish accident-prevention measures across all its sites.Yuhan said the deceased was not an employee of Yuhan Chemical, but that the incident occurred at the unit's workplace.
Yuhan (KRX:000100) posted a 22.1% year-over-year rise in net income to 47.62 billion won for the second quarter ended June 30 from 39 billion won.Sales jumped 10.4% to 614.04 billion won from 556.17 billion won, according to a Friday filing with the Korea Exchange.
